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2Risk of Human Spaceflight
O’Campo RP, Klaus DM. Applying regression analysis to model the risk of space flight and 
terrestrial activities. Journal of Space Safety Engineering. Sep-Dec 2018;5(3-4): 135-139. 
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Outline
Outline
• Historical spaceflight medical kits/systems
• Historical occurrence of medical conditions
• Upcoming missions and medical challenges
• Medical risk and spaceflight events
• Medical system and technology integration
Objectives
• Describe the key principles of extreme environmental medicine
• Identify the challenges with telemedicine and remote medical support
• Analyze the steps necessary to increase clinical autonomy





Principles of Clinical Medicine for Spaceflight
Eds. Barratt, Pool, 2008
FIGURE 4.1. Mercury medical kits containing items such as antibiot-
ics, decongestants, stimu lants, electrode paste, and medications to 
treat nausea and diarrhea. (Photo courtesy of ASA) 
FIGURE 4.2. Mercury medical kit containing items such as saLine 




Principles of Clinical Medicine for Spaceflight
Eds. Barratt, Pool, 2008
TABU1 4.1. Contents of the Gemini VII medical kit ( IO]. 







Methyl cellulose solution 
Parenteral cycliz inc 
Parenteral mepcridine HO 
Pseudoephedrine HCI 
Tctrncycline HCI 




































F1cURE 4.3. Apollo medical kit containing items such as ski n cream. 
antibiotic ointment, nasal spray. band-aids. and stimu lants (Photo 
councsy of ASA) 
F1cURE 4.4. Apollo Command Module medical kit (Photo counesy 
of NASA) 
FIGURE 4.5. Apollo clinical physiological monitoring kit and emer-
gency medical kit (Photo counesy of ASA) 
- - - ~-UI 
FIGURE 4.6. Apollo emergency medical kit (Photo counesy of ASA) 
Space Shuttle
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Principles of Clinical Medicine for Spaceflight
Eds. Barratt, Pool, 2008
FIGURE 4.7. Shuttle Orbiter Medical System. Following redesign in 
2000, components include Saline Supply Bag, EENT Subpack, IV 
Administration Subpack, Trauma Subpack, Sharps Container, Drug 
Subpack, and Airway Subpack (Photo courtesy of NASA) 
Health and Medical on ISS
7
Principles of Clinical Medicine for Spaceflight
Eds. Barratt, Pool, 2008
CHeCS 
I I 
CMS EHS HMS 
F 1GURE 4.8. ISS Health Maintenance System. Components include 
(from left) defibrillator, Advanced Life Support Pack, Respiratory 
Support Pack, and Crew Medical Restraint System (Photo cou1tesy 
of NASA). 
Do we need medicine in spaceflight?
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Antonsen E, Bayuse T, Blue RS, Daniels V, Hailey M, Hussey S, et al. The Risk of Adverse Health 
Outcomes and Decrements in Performance due to In-Flight Medical Conditions. National Aeronautics 
and Space Administration 2017; TR: NASA/TR-2017-0004604
Medical cond ition Events Medical condition Events 
Allergic reaction (mild lo Mou1h ulcer 
11 9 
moderate) 
Ankle sprain/strain 11 Nasal congestion (space adaptation) 389 
Back injury 31 Neck injury 9 
Back pain (space adaptation) 382 Nose bleed (space adaptation) 6 
Barotrauma (ear/sinus block) 31 Otitis extema 3 
Choking/obstructed airway 3 Otitis media 3 
Constipation (space Paresthesias 
11 3 26 
adaptation) 
Diarmea 33 Pharyng itis 11 
Elbow sprain/strain 12 Respiratory infection 33 
Eye abrasion (foreign body) 70 Shoulder sprain/strain 22 
Eye chemical bum 6 Sinusitis 6 
Eye infection 5 Skin abrasion 94 
Finger dislocation 1 Skin infection 13 
Fingernail delamination (EVA) 16 Skin laceration 1 
Gastroenteritis 4 Skin rash 94 
Headache (CO2 induced) 20 Smoke inhalation 3 
Headache (late) 49 Space motion sickness (space adaptation) 325 
Headache (space adaptation) 233 Urinary incontinence (space adaptation) 5 
Hemormoids Urinary retention (space adaptation) -
2 5 
female 
Herpes Zoster reactivation 
1 
Urinary retention (space adaptation) - male 
4 (shingles) 
Indigestion 6 Urinary tract infection - female 5 
Influenza 1 Urinary tract infection - male 4 
Insomnia (space adaptation 
299 
Visual impairment/increased intracranial 
15 
pressure (space adaptation) 
Insomnia (late) 133 Wrist sprain/strain 5 
Knee sprain/strain 7 
How is medical care provided in mission?
• Live remote guidance
\
• Live monitoring
• Store and forward
9
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EXPLORATION SPACEFLIGHT
10
NASA Human Spaceflight Missions
• Soyuz Launch and Landings
• International Space Station
• Commercial Crew Program
• Multi-Purpose Crew Vehicle
• Gateway Habitat
• Deep Space Transport
• Mars Missions
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Near Term (Current - 5 yrs)
Medium Term (within 10 yrs)








2. Isolation and Confinement
3. Altered Gravity Fields
4. Hostile/closed environments
5. Distance from Earth
A Mars mission cannot use the current operational medical 
approach because that approach is dependent on 














S. Love, E. Nelson, Mars Mission Concept of Operations, Aug 2016  
Access to  the Deep Space Network for the vehicle may 
be as limited as 1 hour in a 24 hour period.
A Mars mission cannot use the current operational medical 
approach because that approach is totally dependent 
on real-time communication with the ground. 
17
A Mars mission cannot use the current operational 
medical approach because that approach requires 
frequent resupply.
18
A Mars mission cannot use the current operational medical approach 
because that approach requires significant, continuous ground support.
Paradigm Shift
19
How do we scope a medical system to meet the needs of a 
planetary mission that is: 
2-3 times as long as any prior mission
>500 times as far as any prior mission



































Atrial Fibrillation / Atrial Flutter




















Toxic Exposure:  Ammonia
Smoke Inhalation
Chest Injury
*SA – Space Adaptation
NEUROLOGIC






































































Medical Conditions for which we have not planned.
Spaceflight Medical Risk
22
How do we extrapolate human system risk?
• Lack of single source for data
• Flight data- high internal validity, small volume
• Analog data- Lower validity, higher volume
• Expert opinion
Extrapolating Medical Risk























• Loss of Crew Life 
(LOCL)






























Proportion of Mission Risk attributable to Medical
Launch 
J 
730 Mars Transit 




14 Space Shuttle 
Mission Risk (LOG) 
Some IMM Assumptions…
1. All diagnoses are 100% accurate.
2. All events receive appropriate treatment.
3. All meds and equipment are 100% reliable and effective.
4. All events respond as they would terrestrially.
5. No mistakes in medical procedures (regardless of training)









21 Day Lunar 6 Month ISS 1 Year ISS 2.5 Years Mars
Perfect





Slide courtesy of E Kerstman
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Proportion of Mission Risk attributable to Medical
Launch 
J 
730 Mars Transit 




14 Space Shuttle 
Mission Risk (LOG) 
“…[The] assumption has been that
risk of vehicle system
malfunction far outweighs the
risk of human system
failure…NASA buys down the risk
of failure of the human system
through rigorous selection of
individuals designed to minimize
medical issues and optimize
available capability in flight.”
NASA SP-2017-0633
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ENGINEERING, LIFE SCIENCES, 
AND HEALTH/MEDICINE SYNERGY 
IN AEROSPACE HUMAN SYSTEMS INTEGRATION 
THE ROSETTA STONE PROJECT 
Ed1t0d by Richard S. Williams and Charles R. Doarn 
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• Protect from environmental hazards
– Radiation protection
– Noise, vibration, CO2, etc.
• Keep healthy crew well
– Exercise
– Other physiological countermeasures
– Food
– Behavioral health
• Prevent, diagnose, treat, manage long-term health care
– Data system









Crew Health and Performance System Must…
33
System Performance Threatened by Sleep Deficit
Biomonitoring 
Emergency response / 
Medical Equipment 
Medical Skills Maintenance 
Pharmacy 











/E . E . / xerc1se qu1pment 
CO2 Levels 
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Medical Skills Maintenance 
Pharmacy 







I Team Cohesion I 
I Team Dynamics I 
Physical Strength 
/ Exercise Equipment 
CO2 Levels 




Do we have the capabilities to 
meet the needs?
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Medical and Non-medical Risk
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These technologies exist today
Medical
We’re not bringing an Intensive Care Unit but…
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Metadata & Data Standards
Data Virtualization






Databases Data Warcrouse Dependenl Data Marts 
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Areostationar Satellite 
Mission: Primary - Comm Relay; secondary - Science/Explor,l.tion 
Continuous relay availability for surface assets -' 
High availability for low-altitude orbiters and CubeSats 
High-performance directional prox1m1ty lmks 
Hii:h -performance Earth link 
Low-Altitude Science Orbiter 
Mission: Prime - Science/Exploration; secondary - Comm Rela 
• High-performance Earth link for science data return 
• Intermittent relay services 1-20 min/sol to Surface Asset) 
.,. 
• Low-rate command and telemetry on Earth link 
• Continuously available high-rate relay link via 
Areostationary Relay Satellite 
• Intermittent high-rate relay to science orbiter(s) 
Communication Technolo ies 
• New! Deep space optical communications: smaller, llghter, 
lower power flight terminals combined with large aperture 
ground telescopes offer 10-l00x higher data rates 
Advanced deep ,pace RF communications: higher power and 
frequency, larger aperture, and sophisticated processing offer 
10-20x higher data rates 
Figure 1. Advanced RF and optical communications technolog ies combined with using the areostationary 
orbit offer 100-1000x greater data return from Mars and nearly continuous avai labil ity. 
Table 1. High-Performance Mars-Earth Trunk Line Capabil ity 
I Frequency I Maturity I 5/C I 5/C Txmt I Ground Receiver I Data Rate Band Aperture Power (@2 AU) 
Current Operational 3m 100W 34 m DSN BWG 1 Mb/s 
State-of-the- X-band antenna 
Art (MRO) 
TRL 6 3m 200 W 34 m DSN BWG 5 Mb/s 
Ka-band antenna 
TRL 3-4 5m 1 kW 34 m DSN BWG 70 Mb/s 
Next- antenna 
Generation TRL 6 (DSOC; to fly 22 cm 4W 5 m ground 1 Mb/s 
Trunk Line on 2023 Psyche telescope Options Optical Discovery Mission (1 550 nm) 
TRL 3 50 cm 50W 12 m ground 100 Mb/s 
telescope 





Fly• Full Artificial Intelligence
• Integrative Health and Performance Prediction
• Condition Specific Guidance
• Differential Diagnosis Generation
• Automated Image/Data Analysis
• Knowledge Support/Known Algorithm Provision
• Preventive Care Strategies
Autonomy - COMfORT
Fundoscopy – Retinal Imaging
Intubation Emergency









Perform physical exam, and collect vitals. 
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TAKING A Gooo IMAGE: COMPOSITION 
T ips fo r good compos it io n: 
To move the optic disc dawn the 
subject needs to look up. 
To move the optic disc right the 
subject needs to look right. 
In a good composition the optic 
disc is centered. 
Goad composit ion 
Toking Im ages Eye =>a hology,,__ ________________ ~-
Bad composit ion 
In poor composit ion, the optic disc is not centered or not visible. 
Bad composition 
Optic disc is too far right 
Bad composit ion 
Optic disc is too low 
Medical Technology Development
47
SEEQ Mobile Cardiac Telemetry System: Medtronic
FUS moving stone in ER patient.
Reveal LINQ ICM 
PHARMACY
48





Du et al. 2011





* Drug tested only for Vit B API
** Drug would fail by today’s API standard
† drug had unidentified degradant product
- - J Ground Control Available 
I 
Acyclovir Lidocaine 
Amoxicillin/Clavula nate Metoprolol 
Atorvastatin Metronidazole 
Azithromycin Mupirocin 




Epinephrine Rised ro nate 
Fluconazole Sertraline 
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API and Physical Characteristics 
API (B Vitamin only) 
I I Centrum Silver4> Multivitamin• I API 



































• From Conclusion 6: 
• “The human being 
must be integrated 
into the space 
mission in the same 
way in which all other 
aspects of the 
mission are 
integrated.” 
Committee on Creating a Vision for Space Medicine During Travel Beyond Earth 
Orbit, Board on Health Sciences Policy and I. O. Medicine, Safe Passage: 
Astronaut Care for Exploration Missions, Institute of Medicine of the National 




National Ar.<onautics and I N&·j'& I 
SpacoAdm1nl• tratJcn •~:_,/ 
ENGINEERING, Llf E SCIENCES, 
AND HEALTH/MEDICINE SYNERGY 
IN AEROSPACE HUMAN SYSTEMS INTEGRATION 
THE ROSETTA STONE PROJECT 
Edited by Richard S. Williams and Charles R. Doarn 
Questions?
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benjamin.easter@nasa.gov
